Edition:
United Kingdom

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

403.20INR
23 May 2018
Change (% chg)

Rs11.15 (+2.84%)
Prev Close
Rs392.05
Open
Rs396.00
Day's High
Rs440.50
Day's Low
Rs396.00
Volume
24,064,339
Avg. Vol
1,292,519
52-wk High
Rs1,102.20
52-wk Low
Rs333.30

Latest Key Developments (Source: Significant Developments)

Strides Shasun Appoints Arun Kumar As Group CEO And MD
Friday, 18 May 2018 

May 18 (Reuters) - Strides Shasun Ltd ::SAYS ARUN KUMAR TO BE GROUP CEO AND MANAGING DIRECTOR OF THE COMPANY .SAYS DEEPAK VAIDYA TO BE THE CHAIRMAN OF THE BOARD OF DIRECTORS OF THE COMPANY.  Full Article

India's Strides Shasun March-Qtr Consol Profit Rises Five-Fold
Friday, 18 May 2018 

May 18 (Reuters) - Strides Shasun Ltd ::MARCH QUARTER CONSOL NET PROFIT 5.68 BILLION RUPEES VERSUS PROFIT OF 1.12 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 6.64 BILLION RUPEES VERSUS 6.77 BILLION RUPEES LAST YEAR.  Full Article

India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets
Wednesday, 2 May 2018 

May 2 (Reuters) - Strides Shasun Ltd ::STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS.PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT PUDUCHERRY.PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN THE U.S. MARKET.  Full Article

India's Strides Shasun Gets U.S. FDA Nod For Cyproheptadine Hydrochloride Tablets
Thursday, 12 Apr 2018 

April 12 (Reuters) - Strides Shasun Ltd ::GETS USFDA APPROVAL FOR CYPROHEPTADINE HYDROCHLORIDE TABLETS.PRODUCT WILL BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE.PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN U.S MARKET.SAYS DRUG IS INDICATED TO RELIEVE ALLERGY SYMPTOMS.  Full Article

Strides Shasun Gets U.S. FDA Approval For Efavirenz Tablet
Wednesday, 14 Mar 2018 

March 14 (Reuters) - Strides Shasun Ltd ::SAYS CO GETS U.S. FDA APPROVAL FOR EFAVIRENZ TABLET.PRODUCT TO BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE; MARKETED BY STRIDES PHARMA INC IN U.S. MARKET.  Full Article

Strides Shasun Acquires Controlling Stake In Trinity Pharma
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Strides Shasun Ltd ::SAYS ACQUIRES CONTROLLING STAKE IN TRINITY PHARMA, SOUTH AFRICA.UNDER AGREEMENT, STRIDES PHARMA ASIA PTE LTD, SINGAPORE WILL ACQUIRE 55 PERCENT STAKE IN TRINITY FOR 55 MILLION SOUTH AFRICAN RAND‍​.CURRENT MANGEMENT WILL STAY AS MINORITY PARTNER AND RUN THE BUSINESS UNDER SUPERVISION OF STRIDES‍​.  Full Article

Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Eris Lifesciences Ltd ::SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED.  Full Article

Strides Shasun gets U.S. FDA approval for acetazolamide tablets​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Strides Shasun Ltd :Says ‍receives USFDA approval for acetazolamide tablets​.Says product to be marketed by Strides Pharma Inc in the US market‍​.  Full Article

India's Strides Shasun Sept-qtr consol profit down 87 pct
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Strides Shasun Ltd ::Sept quarter consol net profit 107.3 million rupees versus profit of 854.3 million rupees last year.Sept quarter consol revenue from operations 9.96 billion rupees versus 8.72 billion rupees last year.  Full Article

Strides Shasun gets USFDA approval for cetirizine softgel capsules
Monday, 24 Jul 2017 

July 24 (Reuters) - Strides Shasun Ltd ::Says receives USFDA approval for cetirizine softgel capsules.Says product is ready for launch immediately.Says product will be manufactured at co's Bangalore facility and marketed by Strides Pharma Inc in U.S.‍​.  Full Article